# Uva Ursi (Arctostaphylos uva-ursi)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/uva-ursi
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 6 / 10
**Category:** European
**Also Known As:** Arctostaphylos uva-ursi, Bearberry, Kinnikinnick, Sandberry, Hog Cranberry, Mealberry, Mountain Cranberry, Bear's Grape

## Overview

Uva ursi contains arbutin, which converts to hydroquinone in alkaline urine, providing [antimicrobial](/ingredients/condition/immune-support) activity against urinary tract infection pathogens like E. coli. Clinical evidence shows mixed results for UTI treatment, with some studies indicating increased symptom burden despite potential antimicrobial effects.

## Health Benefits

• May reduce antibiotic use in uncomplicated urinary tract infections (UTIs) - though evidence shows mixed results with increased symptom burden (PMID:34111592)
• Traditional [antimicrobial](/ingredients/condition/immune-support) effects against UTI pathogens like E. coli through hydroquinone metabolites in alkaline urine - mechanism-based evidence only
• Potential diuretic properties based on 2000+ years of traditional European and Native American use - no clinical trials identified
• May serve as an alternative to antibiotics for uncomplicated lower UTIs in women - though ATAFUTI trial showed no difference in symptom severity (PMID:30685500)
• Possible urinary antiseptic effects when urine pH >7 - based on known mechanism of arbutin hydrolysis, not clinical outcomes

## Mechanism of Action

Uva ursi's arbutin glycoside is hydrolyzed in the intestines and converted to hydroquinone in alkaline urine (pH >7). Hydroquinone exerts [antimicrobial](/ingredients/condition/immune-support) activity against gram-negative bacteria like E. coli by disrupting bacterial cell membranes and interfering with cellular [metabolism](/ingredients/condition/weight-management). The effectiveness depends on urinary pH, requiring alkaline conditions for optimal hydroquinone formation and antibacterial activity.

## Clinical Summary

A 2021 systematic review (PMID:34111592) found mixed evidence for uva ursi in treating uncomplicated UTIs, with some studies showing potential reduction in antibiotic use but others indicating increased symptom burden. Most clinical trials have been small-scale with methodological limitations, making definitive efficacy conclusions difficult. Traditional use supports [antimicrobial](/ingredients/condition/immune-support) properties, but high-quality randomized controlled trials are limited. Current evidence suggests modest benefits that may not outweigh potential risks in all patients.

## Nutritional Profile

Uva ursi is consumed as a medicinal herbal preparation (leaf tea, extract, or capsule), not as a food, so traditional macronutrient profiling (calories, protein, fat, carbohydrates) is not applicable at typical therapeutic doses. Key bioactive compounds include: • **Arbutin (hydroquinone-β-D-glucopyranoside)**: 5–15% of dried leaf weight (primary active constituent); undergoes hydrolysis in alkaline urine to release hydroquinone, the [antimicrobial](/ingredients/condition/immune-support) metabolite. Standardized extracts typically deliver 100–210 mg arbutin per dose (equivalent to ~400–800 mg arbutin per day in divided doses). Bioavailability: arbutin is well absorbed orally and metabolized via gut microbiota and hepatic conjugation; urinary hydroquinone release is pH-dependent (optimal at urine pH >8). • **Free hydroquinone**: 0.1–0.5% of dried leaf; contributes directly to antimicrobial activity but also to hepatotoxicity concerns at high doses. • **Tannins (gallotannins and ellagitannins)**: 15–20% of dried leaf weight, including **corilagin**, **gallic acid**, and **ellagic acid**; responsible for astringent properties and may contribute to [anti-inflammatory](/ingredients/condition/inflammation) and antidiarrheal effects. High tannin content may reduce bioavailability of co-ingested nutrients and medications. • **Flavonoids**: including **hyperoside** (quercetin-3-O-galactoside, ~0.5–1%), **isoquercitrin**, **myricetin glycosides**, and **myricitrin**; contribute [antioxidant](/ingredients/condition/antioxidant) and mild anti-inflammatory activity. • **Iridoid glycosides**: including **monotropein** (trace to ~0.5%). • **Triterpenes**: **ursolic acid** (~0.4–0.8%) and **oleanolic acid**; associated with anti-inflammatory and [hepatoprotective](/ingredients/condition/detox) properties in preclinical models. • **Phenolic acids**: including **gallic acid** (~1–2%), **p-coumaric acid**, and **syringic acid**. • **Allantoin**: trace amounts; traditionally associated with tissue-soothing properties. • **Minerals**: Leaf material contains modest amounts of calcium, potassium, magnesium, and manganese typical of woody shrub foliage, but quantities delivered at therapeutic doses (1.5–4 g dried leaf/day) are nutritionally negligible. • **Vitamins**: No significant vitamin content at medicinal doses. • **Fiber**: Dried leaf contains insoluble plant fiber, but amounts consumed medicinally are too small to be dietarily relevant. Bioavailability notes: Arbutin absorption is rapid (Tmax ~1–2 hours); however, antimicrobial efficacy depends on urinary alkalinization (traditionally achieved by co-administration of sodium bicarbonate or alkaline diet). Tannin content may cause gastrointestinal irritation and reduce absorption of iron, alkaloids, and certain medications if co-administered. Prolonged use (>1–2 weeks) or high doses risk cumulative hydroquinone toxicity (hepatotoxicity, nephrotoxicity). The European Medicines Agency (EMA) recommends limiting use to 1 week and no more than 4 treatment episodes per year.

## Dosage & Preparation

Clinically studied dosages include uva-ursi leaf extract standardized to 20-25% arbutin content, with doses of 500-1000 mg/day for 4-7 days based on traditional use patterns in trials. Maximum studied duration is 28 days for UTI treatment. No powder forms have been studied in clinical trials. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Uva ursi contains high levels of tannins that can cause gastrointestinal irritation, nausea, and vomiting with prolonged use. Hydroquinone metabolites may cause liver toxicity with extended consumption beyond 5 days or repeated courses. The herb can interact with medications that acidify urine, reducing its effectiveness, and may potentiate lithium toxicity. Pregnant and breastfeeding women should avoid uva ursi due to potential uterine stimulation and lack of safety data.

## Scientific Research

Clinical evidence is limited to small RCTs in women with uncomplicated UTIs. The ATAFUTI trial (382 women, PMID:30685500) found no difference in symptom severity between uva-ursi and placebo, while Gágyor et al. (2021, PMID:34111592) reported reduced antibiotic use but increased symptom burden compared to fosfomycin. The REGATTA trial protocol (PMID:29970072) and ongoing NCT05055544 study aim to assess non-inferiority versus antibiotics.

## Historical & Cultural Context

Uva ursi has been used for approximately 2000 years in European and Native American traditional medicine for urinary tract complaints, including cystitis and urethritis. It is promoted in German guidelines as an alternative treatment for UTIs and has been traditionally employed as a diuretic and urinary antiseptic.

## Synergistic Combinations

Methenamine, Sodium bicarbonate, D-mannose, Cranberry extract, Vitamin C

## Frequently Asked Questions

### How long can you safely take uva ursi?

Uva ursi should not be used for more than 5 consecutive days or more than 5 times per year due to hydroquinone toxicity risks. Extended use can cause liver damage and gastrointestinal problems from high tannin content.

### What foods make uva ursi more effective?

Foods that alkalinize urine enhance uva ursi effectiveness, including citrus fruits, vegetables, and avoiding cranberry juice. Alkaline urine (pH >7) is necessary for arbutin conversion to active hydroquinone, so dietary modifications support the herb's antimicrobial action.

### Can uva ursi prevent recurring UTIs?

Limited evidence supports uva ursi for UTI prevention, with mixed clinical results showing potential benefits but also increased symptom burden in some patients. Its effectiveness for prevention is not well-established compared to acute treatment applications.

### What is the typical uva ursi dosage for UTI?

Traditional dosing ranges from 400-800mg of standardized extract (10% arbutin) taken 2-4 times daily with meals. However, clinical studies show inconsistent dosing protocols, and professional guidance is recommended due to safety concerns with hydroquinone exposure.

### Does uva ursi interact with antibiotics?

Uva ursi may reduce antibiotic effectiveness if used simultaneously, as some antibiotics work better in acidic urine while uva ursi requires alkaline conditions. The herb should not replace prescribed antibiotics for serious UTIs without medical supervision.

### Is uva ursi safe during pregnancy and breastfeeding?

Uva ursi is not recommended during pregnancy due to limited safety data and its potential uterine stimulant properties, which could increase miscarriage risk. It is also not advised during breastfeeding, as hydroquinone metabolites may pass into breast milk and affect nursing infants. Pregnant and nursing women should consult a healthcare provider before considering this herb.

### What does clinical research actually show about uva ursi's effectiveness for UTIs?

Clinical evidence for uva ursi in UTI treatment is mixed; while traditional use spans over 2,000 years, modern studies show variable results with some trials reporting increased symptom burden despite antimicrobial potential. The herb's mechanism relies on hydroquinone metabolites that require alkaline urine to be effective, which limits its activity in acidic conditions. More rigorous, large-scale clinical trials are needed to establish its efficacy compared to standard antibiotic treatment.

### Who should avoid uva ursi or use it with caution?

Uva ursi should be avoided by pregnant and nursing women, children under 12, and individuals with kidney disease or severe liver impairment due to potential toxicity of its metabolites. People taking medications that acidify urine (such as vitamin C supplements or certain diuretics) may reduce uva ursi's effectiveness, while those with ulcers or gastrointestinal sensitivity should use it cautiously as it may cause gastric irritation. Anyone with a history of hydroquinone sensitivity should also avoid this ingredient.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*